Yes, they are the same as all the Qs before. Kyle is very careful in how he words his Qs. That is the difference between this company and most in the OTC. He has the experience and know how. The SEC will not have any issue with this one. He is brutally honest. FINS are really of no issue with start ups, if every one of them were honest their reports would look the same. Under promise and over perform. Personally I like his way of thinking!